2002, ISBN 8481600873, 189
Book
1996, 1. ed., Tezontle., ISBN 9789681650070, 267
Book
Book
2008, ISBN 9789689053033, 163
Book
2009, 1. ed., Colección H, ISBN 9786079506469, 159
Book
1993, Historia viva, ISBN 8486898234, Volume 6., 223
Book
2005, 1. ed., Llibros del Pexe, ISBN 9788496117372, Volume 56, 230 p., [32] p. de lám.
Book
2008, ISBN 9788496849402, 182
Book
1946, 1. ed., Centro de Estudios Literarios de el Colegio de México. [Publicaciones] 6, 155
Book
Scientia Marina, ISSN 0214-8358, 01/2017, Volume 81, Issue 4, pp. 517 - 518
Journal Article
SCIENTIA MARINA, ISSN 0214-8358, 12/2017, Volume 81, Issue 4, pp. 517 - 518
Journal Article
1968, Biblioteca America Latina. Serie menor, v. 8, 183
Book
1950, 3. ed., Biblioteca de grandes biografías, ser. A, v. 2, 411
Book
1996, Estudios, Volume no. 18, 20
Book
15.
El alba y el sol
2010, Juan de la Cuesta Hispanic monographs. Series Ediciones críticas, ISBN 9781588711595, Volume 55, 422
Book
1992, Colección de poesía ciudad de Cáceres, ISBN 9788460610212, 394
Book
1997, ISBN 9788489796812, 91
Book
18.
Full Text
Genetic diversity of the Mycobacterium tuberculosis Complex in San Luis Potosí, México
BMC Research Notes, ISSN 1756-0500, 2013, Volume 6, Issue 1, pp. 172 - 172
Although epidemiologic and socioeconomic criteria and biomedical risk factors indicate high-priority for tuberculosis (TB) control in Mexico, molecular...
Spoligotypes | Social determinants of tuberculosis | Tuberculosis | Mycobacterium bovis | Molecular epidemiology | Mexico | San Luis Potosí | Genes, Bacterial | Tuberculosis, Pulmonary - microbiology | Humans | Middle Aged | Antitubercular Agents - pharmacology | Male | Mycobacterium tuberculosis - drug effects | Genetic Variation | Microbial Sensitivity Tests | Young Adult | Adolescent | Aged, 80 and over | Adult | Female | Aged | Mycobacterium tuberculosis - genetics | Jurisdiction | Studies | Health services | Socioeconomic factors | Population | Epidemiology | Public health | Data processing
Spoligotypes | Social determinants of tuberculosis | Tuberculosis | Mycobacterium bovis | Molecular epidemiology | Mexico | San Luis Potosí | Genes, Bacterial | Tuberculosis, Pulmonary - microbiology | Humans | Middle Aged | Antitubercular Agents - pharmacology | Male | Mycobacterium tuberculosis - drug effects | Genetic Variation | Microbial Sensitivity Tests | Young Adult | Adolescent | Aged, 80 and over | Adult | Female | Aged | Mycobacterium tuberculosis - genetics | Jurisdiction | Studies | Health services | Socioeconomic factors | Population | Epidemiology | Public health | Data processing
Journal Article
The Lancet, ISSN 0140-6736, 10/2018, Volume 392, Issue 10157, pp. 1519 - 1529
Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular...
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment
MEDICINE, GENERAL & INTERNAL | RISK | METAANALYSIS | MELLITUS | SAFETY | RECEPTOR AGONISTS | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Stroke - prevention & control | Double-Blind Method | Drug Administration Schedule | Glucagon-Like Peptide 1 - administration & dosage | Glucagon-Like Peptide 1 - analogs & derivatives | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Treatment Outcome | Stroke - etiology | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Adult | Female | Aged | Myocardial Infarction - prevention & control | Diabetes Mellitus, Type 2 - drug therapy | Myocardial Infarction - etiology | Diabetes Mellitus, Type 2 - complications | Glucagon-Like Peptide 1 - therapeutic use | Myocardial infarction | Diabetic retinopathy | Heart attacks | Peptides | Glucagon | Medical services | Clinical trials | Cardiovascular disease | Thyroid gland | Incidence | Thyroid carcinoma | Randomization | Motivation | Hemoglobin | Diuretics | Diabetes mellitus (non-insulin dependent) | Glucagon-like peptide 1 | Thyroid | Cerebral infarction | Stroke | Diabetes mellitus | Pancreatitis | Health risks | Risk reduction | Disease control | Patients | Organic chemistry | Interactive systems | Pancreatic cancer | Fatalities | Infarction | Diabetes | Cardiovascular diseases | Health risk assessment
Journal Article
Bulletin of Hispanic Studies, ISSN 1475-3839, 2015, Volume 92, Issue 4, pp. 385 - 410
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.